Dr. Frank Mathias, Chief Executive Officer of OXB, said, “We are delighted that Boehringer Ingelheim is using OXB’s proprietary lentiviral vector manufacturing technology, to produce lentiviral vector ...
The global viral vector and plasmid DNA manufacturing market size is calculated at USD 8.66 billion in 2025 and is expected ...
Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...
AAV-Navβ1 gene therapy effectively reduces seizures and prolongs life in a mouse model of SCN1B-linked Dravet syndrome, ...
The AAV Innovation Summit 2025, hosted by Form Bio, will bring together top experts in gene therapy to discuss the latest ...
Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...
One of the original pioneers in cell and gene therapy, OXB has more than 25 years of experience in viral vectors; the driving force ... development and manufacturing expertise in lentivirus, ...
One of the original pioneers in cell and gene therapy, OXB has more than 25 years of experience in viral vectors ... expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other ...
NEW ORLEANS (AP) — Patrick Mahomes, Travis Kelce and the Kansas City Chiefs are pursuing history and a few of Taylor Swift’s records. Saquon Barkley, Jalen Hurts and the Philadelphia Eagles stand in ...